AbbVie Inc. (ABBV): Price and Financial Metrics

ABBV POWR Grades

• ABBV scores best on the Value dimension, with a Value rank ahead of 92.89% of US stocks.
• ABBV's strongest trending metric is Growth; it's been moving up over the last 52 weeks.
• ABBV's current lowest rank is in the Momentum metric (where it is better than 18.97% of US stocks).

ABBV Stock Summary

• ABBV has a market capitalization of $192,198,010,860 -- more than approximately 98.89% of US stocks.
• Equity multiplier, or assets relative to shareholders' equity, comes in at 10.96 for AbbVie Inc; that's greater than it is for 93.34% of US stocks.
• In terms of volatility of its share price, ABBV is more volatile than just 3.28% of stocks we're observing.
• Stocks with similar financial metrics, market capitalization, and price volatility to AbbVie Inc are NVS, TXN, AZN, SAP, and CSCO.
• ABBV's SEC filings can be seen here. And to visit AbbVie Inc's official web site, go to www.abbvie.com.

ABBV Valuation Summary

• ABBV's EV/EBIT ratio is 33.9; this is 15.7% higher than that of the median Healthcare stock.
• ABBV's EV/EBIT ratio has moved up 18.8 over the prior 105 months.
• ABBV's price/earnings ratio has moved up 15.8 over the prior 105 months.

Below are key valuation metrics over time for ABBV.

ABBV Growth Metrics

• Its year over year price growth rate is now at 37.86%.
• Its 4 year price growth rate is now at 34.31%.
• The 2 year revenue growth rate now stands at 15.01%.

Over the past 30 months, ABBV's revenue has gone up $20,976,000,000.

The table below shows ABBV's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	53,729	20,451	6,663
2021-03-31	50,195	18,650	5,159
2020-12-31	45,804	17,588	4,616
2020-09-30	40,650	16,009	7,381
2020-06-30	36,227	14,734	6,957
2020-03-31	34,057	14,122	8,436

ABBV's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ABBV has a Quality Grade of B, ranking ahead of 77.3% of graded US stocks.
• ABBV's asset turnover comes in at 0.359 -- ranking 134th of 681 Pharmaceutical Products stocks.
• CAPR, HSTO, and BCDA are the stocks whose asset turnover ratios are most correlated with ABBV.

The table below shows ABBV's key quality metrics over time.